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2. Abstract 
Contemporary theories propose that dysregulation of emotional perception is involved in the aetiology of psychosis. 
298 healthy adolescents were assessed at age 14- and 19-years using fMRI while performing a facial emotion task. 
Psychotic-like experiences (PLEs) were assessed with the CAPE-42 questionnaire at age 19. The high PLEs group at 
age 19 years exhibited an enhanced response in right insular cortex and decreased response in right prefrontal, right 
parahippocampal and left striatal regions; also, a gradient of decreasing response to emotional faces with age, from 14 
to 19 years, in the right parahippocampal region and left insular cortical area. The right insula demonstrated an 
increasing response to emotional faces with increasing age in the low PLEs group, and a decreasing response over 
time in the high PLEs group. The change in parahippocampal / amygdala and insula responses during the perception 
of emotional faces in adolescents with high PLEs between the ages of 14 and 19 suggests a potential ‘aberrant’ 
neurodevelopmental trajectory for critical limbic areas. Our findings emphasize the role of the frontal and limbic areas 
in the aetiology of psychotic symptoms, in subjects without the illness phenotype and the confounds introduced by 
antipsychotic medication.  
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3. Manuscript Text 
Introduction 
Psychotic-like experiences (PLEs) describe transitory phenomena that, if they persist, can lead to clinically relevant 
symptoms with functional impairment.1 A developmental model of psychosis describes transitory symptoms, such as 
PLEs and attenuated psychotic symptoms (psychosis proneness) becoming abnormally resilient (persistence) and 
subsequently clinically relevant (symptoms of clinical psychosis and impairment). This model is in line with the 
contemporary view that psychotic symptoms are not “all-or-nothing” pathological phenomena but rather fall within a 
spectrum ranging from normal, transient PLEs to pervasive psychotic symptoms, conceptualised as the continuum 
model of psychosis.2 This view is supported by the high prevalence rates of sub-clinical delusional or hallucinatory 
experiences in the general population (10% and 30%), which is substantially higher than the prevalence rate of 
psychotic disorders.3 In support of this model, structural brain abnormalities evident in adults with psychosis are also 
observed in adolescents with psychotic symptoms and free from the confound of medication effects.4  
Late adolescence is a critical neurodevelopmental period, flagged by ongoing changes in brain structure and neural 
circuitry. These changes can be principal for the development of psychosis, as supported by the observation that the 
typical age of its onset occurs between late adolescence and early adulthood. The development of clinical psychosis 
can be a lengthy process, and individuals at increased risk, often referred to as the At-Risk-Mental-State (ARMS), can 
be characterised by using appropriate tools (i.e. the Comprehensive Assessment of the At-Risk Mental State, 
CAARMS, a structured questionnaire administered by clinicians, aiming to detect a variety of attenuated psychotic 
symptoms). Though conversion rates widely vary, approximately 20%-35% of individuals aged 12-35 years who meet 
clinical criteria for a psychosis risk syndrome convert to clinical psychosis within two years.5 During adolescence, 
particular epidemiological factors confer an increased risk for the future development of clinical psychosis; as shown 
by a single and non-replicated longitudinal study, the presence of various degrees of psychotic symptoms at age 11 
years and cannabis use by the age of 15 years increases the likelihood of experiencing symptoms of schizophrenia in 
adulthood.6  
PLEs offer a useful, non-clinical phenotype to study the spectrum of psychotic presentations 7 with the advantages of a 
lack of exposure to the effects of both the illness and antipsychotic medication, and the possibility to study larger, non-
clinical populations. Consequently, there is scope for the early detection and characterisation of PLEs in adolescence; 
the Community Assessment of Psychic Experiences Questionnaire (CAPE) can be the tool of choice, as the most 
widely used community assessment of PLEs.8   
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Patients with schizophrenia have long been recognised as having deficits in emotional processing, manifested as 
dysfunction in the domains of emotional expression, emotional experience (including hedonic responses) and 
emotional recognition (the ability to accurately identify and interpret emotions from other sources, including facial 
expressions);9 this has been attributed to aberrant information processing within a broader neural circuit, including the 
prefrontal cortices and the amygdala. A meta-analysis of  neuroimaging studies of face processing comparing 
schizophrenia patients with healthy controls, showed patients demonstrating statistically significant under-recruitment 
of amygdalae and related regions including the parahippocampal cortex in response to aversive emotional material;10 
reduced activation was also evident  in the right ventrolateral prefrontal cortex (VLPFC) and the right fusiform face 
area (FFA).11 Aberrant activation of the amygdalae and related regions including the parahippocampal cortex during 
processing of emotional stimuli was reflected in an inability to appropriately utilise and contextualise social cues. This 
deficit would naturally lead to  the development of inappropriate suspicion, persecutory beliefs, with further 
impairment of interpersonal functioning.12 Indeed, the insular cortices, caudate 13 and the right parahippocampal gyrus 
14  demonstrate attenuated activation during facial emotion processing in patients with schizophrenia.  
As PLEs offer a unique opportunity to study of psychosis unobstructed by the confounders of antipsychotic 
medication, and there is an observed association between schizophrenia and emotion processing, a reasonable step to 
take is to investigate a similar link between PLEs and emotion processing, employing a relevant neuroimaging task. 
There are only a few studies using neuroimaging during emotion processing tasks to investigate the neural basis of 
PLEs. A study of undergraduate students showed high CAPE scorers manifested greater activation in a number of 
prefrontal regions during reappraisal (reinterpretation of negative pictures); while the amygdala response to negative 
stimuli was decreased through reappraisal in the low scorers; functional connectivity analysis revealed lower 
prefrontal-amygdala coupling in high PLEs subjects.15 Most recently, a functional Magnetic Resonance Imaging 
(fMRI) study employing an adolescent sample of subjects with PLEs (n=27) at age 14 demonstrated increased 
hippocampus/amygdala/middle temporal gyrus and cerebellar activation during processing of neutral faces relative to 
subjects with low degree or absence of PLEs.16  
The aim of the study was to examine whether PLEs in adolescence are associated with altered activation of frontal and 
limbic areas of a brain network, which have shown perturbed activation during facial emotion processing in subjects 
with psychosis. Three hypotheses were evaluated: the presence of elevated PLEs in late adolescence (age 19) will be 
associated with decreased activation of the amygdala / parahippocampal cortex, and associated network including 
prefrontal, insular and caudate regions during a facial emotion task;15,16 the activation within these areas will 
differentially vary between high and low PLEs groups over the time between early (age 14) and late (age 19) 
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adolescence; and the presence of increased PLEs in late adolescence will be associated with deficits in behavioural 
performance during risky and affective decision-making tasks.17  
Methods 
Participants and Settings 
As discussed previously (see acknowledgments), neuroimaging and clinical data of healthy adolescents were obtained 
from the IMAGEN database, https://imagen-europe.com/ accessed in August 2018. The IMAGEN study received 
ethical approval by the ethics research committees of the academic centres at which the study was conducted (London, 
Nottingham, United Kingdom and Dublin, Ireland; Paris, France and Berlin, Hamburg, Mannheim and Dresden, 
Germany). Ethical approval was obtained from the local ethics committee at each study site (London: Institute of 
Psychiatry; Nottingham: University of Nottingham; Dublin: Trinity College Dublin; Paris: National Institute of 
Health and medical Research (INSERM); Berlin: Charité University Berlin; Hamburg: University Medical Center 
Hamburg-Eppendorf; Mannheim: Central Institute of Mental Health Mannheim; Dresden: Technical University 
Dresden (TUD)). 
All research methods were carried out in accordance with local guidelines and regulations. All adult participants 
provided written informed consent; minors provided oral informed consent and written informed consent was obtained 
by their parents or legal guardians. For further information please see our guidelines using the following link: 
www.nature.com/srep/policies/index.html#experimental-subjects.  
The present study was conducted from January 1, 2016 to January 1, 2017, from anonymised data. Our study involved 
no information, either data or images, that could lead to the identification of participants. No such information is 
presented in the present publication. Access to IMAGEN database for the conduction of the present study did not 
require a separate informed consent; a waiver was applied owing to fully anonymised data. We used data collected at 
age 14 and 19. A total of 1,434 adolescents were initially selected based on quality controls and completeness of their 
behavioural and neuroimaging datasets. Two subgroups were assessed at ages 14 and 19 years. Those who scored at 
either high or low PLEs (based on the upper and lower deciles) on the CAPE-42 items instrument (see below) at age 
19 were included in the analysis. The epidemiological features of our sample are described in Table 1, the exclusion 
criteria are listed in the supplement. Our sample included healthy individuals and the presence of major medical, 
neurological, developmental or psychiatric conditions, as well as pregnancy complications, was exclusionary; 
similarly, participants who developed a major psychiatric disorder during the study, were excluded from further 
follow-up.  
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Measures 
The CAPE-42 questionnaire 7 was used as a measure of PLEs in our adolescent population at age 19 years. Based on 
the PDI-21(21-items Peters et al. Delusional Inventory) 18 and PDI-40 (40-items Peters et al. Delusional Inventory),19 
the CAPE-42 is a self-administered tool, including 42 items that are grouped in three dimensions: positive, negative, 
and depressive. Each item is scored for frequency and severity in a scale from 0 to 7; total scores range from 0 to 294. 
Higher scores indicate higher burden of symptoms found in the psychosis prodrome.  
The Cambridge Neuropsychological Test Automated Battery (CANTAB) includes highly sensitive, precise and 
objective measures of cognitive function.20 Our study focused on the Affective Go-NoGo Task (AGN), providing an 
assessment of the information processing biases for positive and negative stimuli; this task was chosen as a proxy for 
‘hot’ cognition (cognitive functions mostly influenced by the individual’s emotional state), as related to the 
inhibitory/affective function of frontal and limbic areas of the brain. Participants completed the AGN at both age 14 
and 19.  
In the Face Task (FT) volunteers are asked to passively watch short black and white video clips presenting faces with 
neutral and angry expressions as well as control non-biological motion stimuli (concentric circles).21 In our study, we 
focused on the contrasts angry faces vs control stimuli, angry faces vs neutral faces and angry and neutral faces vs 
control stimuli, as previously described in the IMAGEN literature. 22,23 Additional literature identified common 
variance in response to ambiguous facial expression.23 Participants completed the FT at both age 14 and 19.  
Details of the CAPE-42, CANTAB AGN and FT are described in the supplement.  
Stratification of the Sample 
We defined two subgroups with high or low PLEs, based on total CAPE-42 scores at age 19 years. Because the 
CAPE-42 total scores did not follow a normal distribution (eFigure 1), we selected participants with high and low 
scores using the upper and lower deciles. This distinction resulted in 149 adolescents in the high PLEs group and 149 
in the low PLEs group. The high group CAPE-42 total score ranged from 91 to 182, corresponding to a standardised 
(per item) score range of 2·17 to 4·33. Cut-off levels in the region of 2.0 per CAPE-42 item (transposed to match our 
rating conventions) provide adequate positive predictive value for transition to psychosis; 24 based on our 
stratification, this level formed the lower bound of the high PLEs group. The two groups were equivalent for 
handedness, age and IQ.  
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fMRI Acquisition and Analysis 
The standardised scanning parameters were selected to be compatible and implementable at all sites and scanners. A 
full description of the scanning protocols, cross-site standardization and quality checks, and pre-processing of 
resulting data are provided elsewhere 25 and also listed in the supplement. 
First-Level Analysis 
Three within-subject contrasts reflecting core face emotional processing, was selected for investigation:  
[Angry Faces] – [Control Stimuli];  
[Angry Faces] – [Neutral Faces];  
[Angry + Neutral Faces] – [Control Stimuli].  
Control stimuli were non-facial motion stimuli. The contrasts were designed to separate emotional salient facial 
stimuli from neutral stimuli, and facial from non-facial stimuli, providing maximum differentiation, and were 
previously used in the IMAGEN population.22 The fMRI scans were conducted at ages 14 and 19 years and were 
analysed using SPM12 (Statistical Parametric Mapping; http://www.fil.ion.ucl.ac.uk/spm Wellcome Trust Centre for 
Neuroimaging). 
Second-Level Analysis 
Preliminary whole-brain analysis revealed no statistically significant correlations between brain activation levels and 
CAPE-42 total scores in the overall sample of 1,434 adolescents; as a consequence, further analysis focused only on 
high and low CAPE-42 scorers and task-related regions of interests for the chosen contrast were collapsed across the 
high and low groups. This approach provided an unbiased estimate of the activation, as the group average 
positive/negative mask is orthogonal to high>low or low>high masks and is also supported by the literature on 
functional localizers.26 As multiple ROIs resulted in this step, we performed a retrospective Bonferoni correction of 
the statistical significance threshold, at a contrast level.  
We have extracted mean brain activation contrasts (parameter estimates) for all the identified ROIs, at the ages of 14 
and 19. In a factorial analysis (Mixed Model 2-way ANOVA), the main effects of time, group and the interaction of 
time x group on brain activation levels were examined by employing a 2-way analysis of variance, with group as fixed 
and subject as random effects. Any main effects or interactions were further examined by post hoc paired and 
unpaired, 2-tailed t tests, with P < 0·05 as the statistically significant threshold. Additional exploratory analyses are 
also reported.  
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Results  
Two groups of adolescents (high PLEs, n=149, 50 [33·6%] male; low PLEs, n=149, 84 [56·4%] male) were compared 
at ages 14 and 19 years. The two groups were equivalent for handedness, age and IQ.  
Results of fMRI Analysis 
Five regions of interest (ROIs) based on previous studies of facial emotion processing in psychosis and UHR for 
psychosis 15,16 were used; the prefrontal cortices, the temporal cortices, the limbic brain and the striatum were included 
for factorial analysis. The ROIs Montreal Neurological Institute (MNI) space coordinates were: left insular cortex (-36 
11 -5), right insular cortex (42, 8, -14), left caudate body (-12, 5, 10), right superior frontal gyrus (6, 65, 31) and right 
parahippocampal gyrus/ including the amygdala (33, -46, -5). One ROI (-36 11 -5) arose from the angry vs neutral 
faces contrast, while all remaining ROIs activated in the angry faces vs control stimuli contrast; no relevant activations 
were noted in the angry plus neutral faces vs control stimuli contrast. Only the right insular cortex ROI (42, 8, -14) did 
not survive a retrospective Bonferoni correction for multiple testing (p=0.016 given a revised threshold at 0.01). 
Figure 1 provides a visual representation of the ROIs; eTable 1 in the Supplement reports the results of the functional 
ROI brain analysis.  
Left Insular Cortex (-36 11 -5) 
There was a significant main effect of group (F1,227=4·5, P=0·03), which was driven by decreased activation in the 
high PLEs group compared to the low PLEs group at age 14 (t=-2·1, P=0·04). There was also a significant main effect 
of time (F1,227=64·7, P<0·0001) which was driven by a decrease in activation from age 14 to age 19 years, (high 
group t=4·9 P<0·0001; low group t=6·4, P<0·0001). Figure 2, Table 2, eTable 2, eTable 3. 
Right Insular Cortex (42, 8, -14) 
There was a significant interaction effect of group*time (F1, 230=7·4, P=0·01) driven by a differential change in the 
groups’ brain activation from age 14 to age 19, showing a relative (non-significant) decrease in the high PLEs group, 
and an increase in the low PLEs group (t=-2·0, P=0·04). Additional exploratory post hoc analysis exhibited increased 
activation of the high PLEs group compared to the low PLEs group at age 14 (t=5·2, P<0·0001). Figure 2, Table 2, 
eTable 2, eTable 3. 
Left Caudate Body (-12, 5, 10) 
There were no significant effects of group*time, nor any main effects of group or time. Additional exploratory 
analysis exhibited decreased activation in the high PLEs group compared to the low PLEs group at age 19 (t=-2·588, 
P=0·01). Figure 2, Table 2, eTable 2, eTable 3. 
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Right Superior Frontal Gyrus (6, 65, 31) 
There was a main effect of group (F1, 230=4·2, P=0·04), which was driven by decreased activation in the high PLEs 
group compared to the low PLEs group at age 19 (t=-2·3, P=0·02). There was also a main effect of time (F1, 230=6·9, 
P=0·01), which was driven by an increase in activation from age 14 to age 19 years, post hoc analyses showed this 
was significant only for the low PLEs group (t=-3·3, P=0·001). Figure 2, Table 2, eTable 2, eTable 3. 
Right Parahippocampal Gyrus / Amygdala (33, -46, -5) 
There was a main effect of group (F1, 230=4·9, P=0·03), which was driven by increased activation in the low PLEs 
group compared to the high PLEs group at age 19 (t=-2·8, p=0·005). There was a main effect of time (F1, 230=12·1, 
P=0·001), which was driven by a decrease in activation from age 14 to age 19 years, post hoc analyses showed this 
was significant only the high PLEs group (t=4·3, P<0·0001). Figure 2, Table 2, eTable 2, eTable 3. 
Results CANTAB measures analysis  
There was a main effect of time on AGN Total Omissions for both positive (F1, 159=58·8, P<0·0001] and negative 
stimuli (F1, 159=50·2, P<0·0001]; this was driven by a decrease, signifying improved performance,  from age 14 to 19, 
across both the high and low PLE groups (high - AGN positive: t=4·5, P<0·0001; AGN negative: t=3·7, P<0·001  and 
low - AGN positive: t=6·3, P<0·0001; AGN negative: t=6·4, P<0·0001). Additional exploratory analysis revealed that 
the high PLEs group scored lower than the low PLEs group on AGN Total Omissions for both positive and negative 
stimuli at age 14 years, which indicates a better performance at inhibitory processing in the high versus the low PLEs 
group. Table 3, eTable 4, eTable 5. 
Correlations between CANTAB measures and brain activation levels 
At age 14, brain activation levels at the right insular region (42, 8, -14) showed negative correlation with AGN Total 
Omissions for both positive and negative stimuli (AGN positive: r=-0·181, P=0·01; AGN negative: r=-0·219, 
P=0·002). At age 19, brain activation levels at the same region showed positive correlation with AGN Total 
Omissions for negative stimuli (r=0·163, P=0·03).  
Discussion 
The main findings of our analysis are summarised in Table 4. Overall, the group with lower CAPE scores showed 
increased activation, compared to the group with higher CAPE scores in the left insula (age 14), the left caudate, the 
right prefrontal and the right parahippocampal areas (age 19); the high CAPE score group exceeded the low CAPE 
score group in activation only in the right insula (age 14).  
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19-year-old subjects with increased CAPE scores, indexing higher PLEs (measured only at age 19), demonstrated 
attenuated activation of the right superior frontal gyrus, the right parahippocampal gyrus / amygdala and the left 
caudate, compared to their peers with lower CAPE scores, indexing lower PLEs – when examined using fMRI during 
a facial emotion perception test. These regions form components of a broader neural circuit responsible for social 
cognition and behaviour, encompassing the amygdalae, the VMPFC, the cingulate cortex, somatosensory cortices, the 
fusiform gyrus and the superior temporal sulcus.27 Misidentification of facial expressions represent a crucial deficit in 
this process, and as observed extensively in the schizophrenia literature, can give rise to impaired social interactions 
and the subsequent elaboration of paranoid and persecutory beliefs. The right parahippocampal gyrus, was also 
observed to show increased activation in controls, compared to schizophrenia patients, during the perception of fearful 
faces.14 In our study, we noticed increased activation in the right parahippocampal gyrus including foci within the 
amygdala in the low PLEs group, at the age of 19, during perception of angry faces. These observations provide 
neuroimaging evidence supporting the extended psychosis phenotype encompassing preclinical and clinical 
presentations.  
While the low PLEs group showed a regular trajectory of increasing activation over time in the right prefrontal and 
right insular cortices with brain maturation, the high PLEs group demonstrated decreased activation of the right 
parahippocampal / amygdala and left insular activation over the same time. This normal increase in frontal activation 
from age 14 to 19 years is thought to reflect a consequence of the increasing prefrontal cortical control evidenced by 
the routine improvement in behavioural impulsivity measures to affective stimuli assessed by the Affective Go-NoGo 
task. Besides, lack of change (or more precisely, a non-significant decrease) in the right insular activation for the high 
PLEs group between the ages of 14 and 19 results in a ‘normalisation’ of an overactivation at age 14, as the low PLEs 
group demonstrates a significant increase in right insular activation between the two timepoints. Our longitudinal 
analysis confirmed that in the high PLEs group, brain activation of a parahippocampal area including foci within the 
amygdala showed an attenuation between the ages of 14 and 19; the same area also demonstrated significantly 
decreased activation in the low PLEs group, at the age of 19. This variation could potentially underpin an ‘aberrant’ 
developmental process, leading to under-recruitment of critical limbic areas during perception of angry faces, 
introducing a risk for the future emergence of psychosis. Between the ages of 14 and 19, the high PLEs group 
compared to the low PLEs group showed no significant change in activation of the prefrontal cortex [6 65 31]; the 
same area remained under-active at the age of 19 in the high PLEs group, which could represent a residual deficit in 
frontal activation.  
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Hypoactivation in frontal areas might represent a trait (pattern of brain activation which persist along various 
timepoints) in the development of psychosis, as it appears in all phases of the continuum, from preclinical to 
schizophrenia. Frontal hypoactivation or ‘hypo-frontality’ has been extensively researched in schizophrenia, in 
relation to a variety of behaviours, including motivation, executive functions and psychotic symptomatology.28 
Another position is that during working memory tasks, patients with schizophrenia can either recruit more extended 
prefrontal resources, or fail to sustain recruitment of adequate prefrontal areas, compared to controls, which eventually 
results in poorer behavioural outcomes. 29 Functional dysconnectivity of fronto-striatal circuitry may represent a risk 
phenotype for psychosis. First-episode psychosis is associated with pronounced dysregulation of cortico-striatal 
systems, characterized most prominently by hypo-connectivity of dorsal and hyper-connectivity of ventral fronto-
striatal circuits.30 A meta-analysis of neurofunctional correlates of vulnerability to psychosis revealed hypoactivation 
of DLPFC and VLPFC as the most common finding in Ultra-High Risk (UHR) and First-Episode Psychosis (FEP) 
populations.31 Our cross-sectional results indeed revealed hypoactivation of prefrontal [6 65 31] and striatal [-12 5 10] 
regions in the high PLEs group at age 19, a finding consistent with perturbed fronto-striatal connectivity.   
Aberrant activation of the amygdala during a face recognition is probably one of neuroimaging hallmarks of 
psychosis. In our study, we identified a large cluster centred in the right parahippocampal gyrus, including the 
amygdalae, hippocampal, and parahippocampal areas, which demonstrated a peak activation at a right 
parahippocampal region, [33 -46 -5], which demonstrated significantly lower activation for the high PLEs group at the 
age of 19. A study employing a similar IMAGEN sample as ours revealed that subjects with PLEs demonstrated, 
among other findings, increased hippocampus/amygdala activation during processing of neutral faces, compared to 
controls. 16 It is of note however that the authors of this study employed a smaller sample (n=27), assessed PLEs at age 
14 only and used a less extended questionnaire focusing on perceptual abnormalities and delusional thoughts. It’s 
relevant that we are assessing a non-clinical group of subjects; thus, our findings are likely to correspond to 
preliminary brain alterations in a trajectory toward psychosis and predate changes that are later seen more consistently 
across the psychosis continuum.   
Our finding of lower left caudate activation at age 19 in the high PLEs group, is of interest. A similar finding in this 
region has been reported by another study, showing that UHR individuals had decreased left caudate activation during 
processing of prosodic voice with negative emotional valence, compared to increases activation in controls 32.   
The neuropsychological assessment showed a decrease in AGN scores from age 14 to age 19 in both the high and low 
PLEs groups, which indicates an improvement in affective/inhibitory control. This change corresponds to findings of 
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decreased limbic activation [33, -46, -5] from age 14 to age 19 in the high PLEs group, and increased frontal 
activation [6, 65, 31] from age 14 to age 19 in the low PLEs group. Knowing that processing of emotional material is 
largely mediated by limbic areas of the brain, while the frontal lobes can exert a top-down inhibitory control in 
subcortical areas, here we detect a dual pattern of achieving improved emotional processing, by either increasing 
‘higher’ cortical control (high PLEs group) or decreasing ‘lower’ limbic activation (low PLEs group). Hyperactivation 
in the limbic system can account for an inability to regulate emotions, and as discussed earlier, emotion regulation 
difficulties can lie at the core of vulnerability to psychosis. 15 
Interestingly, the high PLEs group exhibited a lower rate of omissions in the AGN task, indexing increased 
affective/inhibitory control, compared to the low PLEs group at age 14. This observation cannot be accounted by the 
limited corresponding findings of increased right insular activation [42 8 -14] and decreased left insular activation [-36 
11 -5] in the same group at the same age; neither can be interpreted within the boundaries of the continuum model of 
psychosis. However, similar inconsistencies between neuroimaging findings and cognitive-behavioural measures point 
towards the differences in sensitivity of the two approaches to detect an underlying brain process.33 
Limitations 
There is a number of limitations in our study. Firstly, we selected CAPE upper and lower deciles to stratify our 
sample, as these correspond to cut-off levels roughly equivalent to those associated with psychosis proneness in 
literature (detailed in the section describing the stratification of our sample). The decision to dichotomize our 
population was mainly driven by the need to identify the most / least prone to psychosis individuals in a naturalistic 
sample, given that CAPE-42 scores were still moderate in it. Despite the limitations introduced by the use of 
dichotomization, this was deemed as the most appropriate method to explore the extremes of the psychosis continuum 
in our naturalistic sample. Nevertheless, we eventually ended up with a high PLEs group having a still low average 
total score of 112, considering the full potential range of scoring (0-294). In addition, as we stratified our sample 
retrospectively, based on CAPE-42 scores at age 19 year, and in light of the absence of available scores at age 14 
years or intermediate ages, it was impossible to observe the evolution of PLEs between the two timepoints. We have 
rather arbitrarily viewed the high-PLEs phenotype as a representative for the prodrome for psychosis; however, PLEs 
can have multiple clinical outcomes, thus leading to a variety of psychopathologies, other than florid psychosis or can 
also be associated with non-clinical phenotypes as manifested by a mean lifetime prevalence of >5% of psychotic 
experiences in the general population.34 Obviously, the lack of transition to psychosis data restricts the use of our high 
PLEs group as a measure of the UHR population. There was a greater representation of males in our low vs high PLEs 
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groups; despite male predominance being a common epidemiological finding in this clinical field,35 this may impede 
the generalisability of our results. Moreover, we did not control for gray matter volumetric changes.  
In our study we focused on contrasts involving angry faces aiming at emotional aspects of faces’ processing. It would 
be of interest for future studies to analyse contrasts allowing the detection differences in baseline activation (i.e. 
neutral faces vs control stimuli) which can be suggestive of an aberrant salience processing.36 
Conclusions 
In a previous study from the same IMAGEN sample, we provided evidence for a consistent increase in prefrontal 
activation during reward feedback, in the high PLEs group, between the ages of 14 and 19, which was attributed to a 
compensatory cognitive control mechanism.37 The current study revealed functional alterations in parahippocampal / 
amygdala and insula responses during the perception of emotional faces in adolescents with high PLEs between the 
ages of 14 and 19 suggests a potential ‘aberrant’ neurodevelopmental trajectory for critical limbic areas. The two 
studies complement each other, while employing two different cognitive paradigms to examine the neural basis of 
PLEs in adolescence. Our findings emphasize the role of the frontal and limbic areas in the aetiology of psychotic 
symptoms in line with a continuum model, in a sample of subjects without the illness phenotype and the confounds 
introduced by antipsychotic medication.   
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5. Figures & Tables 
Figure 1: ROIs showing differences in brain activation between low and high PLEs groups. Coronal View; Horizontal Axis: Left=Left, Right=Right; Vertical Axis: Up=Superior, 
Down=Inferior.  
Colour Coding 
Age 14 [42 8 -14]: Right Insular Cortex (H>L) [shown in green] 
[-36 11 -5]: Left Insular Cortex (L>H) [shown in purple] 
Age 19 [-12 5 10]: Left Caudate Body (L>H) [shown in blue] 
[6 65 31]: Right Superior Frontal Gyrus (L>H) [shown in red] 
[33 -46 -5]: Right Parahippocampal Gyrus / Amygdala (L>H) [shown in yellow] 
 
 
 
Figure 2: Mean Brain Activation (Parameter Estimates) at age 14 and 19 for Right Prefrontal ROI [6 65 31], Right and Left Insular ROIs [42 8 -14] & [-36 11 -5] and Right 
Parahippocampal ROI [33 -46 -5]; statistically significant changes at p=0.05 level: for the low PLEs group only in [6 65 31] and [42 8 -14]; for the high PLEs group only in [33 -46 -5]; for 
both the high and low PLEs groups in [-36 11 -5]; SE bars are displayed 
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Table 1: Participant Characteristics and CAPE-42 Score Stratification. 
 CAPE TOTAL HIGH 10% (n=149) CAPE TOTAL LOW 10% (n=149) 
Mean SE SD Mean SE SD 
GENDER (Male %) 33.60%   56.40%   
HANDEDNESS (R %) 85.90%   82.60%   
AGE BL (y) 14.47 0.03 0.39 14.43 0.03 0.38 
AGE FU (y) 19.02 0.06 0.76 18.98 0.06 0.74 
WISC VERBAL SCORE (BL) 111.15 1.32 15.66 106.72 1.27 15.24 
WISC PERFORMANCE SCORE (BL) 108.49 1.33 15.79 105.2 1.20 14.42 
ADRS TOTAL SCORE (FU) 15.89 0.24 2.96 19.7 0.06 0.72 
AUDIT TOTAL SCORE (FU) 7.5 0.44 5.34 5.26 0.32 3.87 
DAST CANNABIS TOTAL SCORE (FU) 1.59 0.21 2.52 0.54 0.08 1.02
CAPE TOTAL SCORE (FU) 111.64 1.74 21.26 9.54 0.39 4.75
CAPE POSITIVE SYMPTOMS SCORE (FU) 33.09 1.27 15.48 3.23 0.24 2.98 
CAPE BIZARRE DELUSIONS SCORE (FU) 13.17 0.97 11.82 0.37 0.09 1.09 
CAPE SOCIAL DELUSIONS SCORE (FU) 19.91 0.54 6.57 2.87 0.21 2.61 
CAPE NEGATIVE SYMPTOMS SCORE (FU) 46.37 0.93 11.37 2.22 0.21 2.61 
CAPE DEPRESSIVE SYMPTOMS SCORE (FU) 32.18 0.61 7.49 4.09 0.21 2.54 
WISC: Wechsler Intelligence Batter for Children 38; the average score is 100; higher scores indicate higher than average intelligence and 
lower scores indicate lower than average intelligence. 
ADRS: Adolescent Depression Rating Scale 39; scores range from 0 to 60; higher scores indicate higher levels of adolescent depression.  
AUDIT: Alcohol Use Disorders Identification Test 40; scores range from 0 to 40; higher scores indicate greater levels of alcohol abuse. 
DAST: Drug Abuse Screening Test 41; scores range from 0 to 10; higher scores indicate greater levels of cannabis abuse.  
CAPE: Community Assessment of Psychic Experiences Questionnaire 7; scores range from 0 to 294; higher scores indicated elevated 
presence of attenuated psychotic symptoms.  
SD: Standard Deviation; SE: Standard Error  
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Table 2: Mean Brain Activation Contrast Parameter Estimates Factorial Analysis. 
 
Type III 
Sum of 
Squares 
df Mean Square F Sig. r 
Right Insular ROI [42 8 -14] Brain Activation 
TIME 0.002 1 0.002 0.002 0.97* 0.003 
GROUP 3.92 1 3.92 19.52 <0.0001 0.28 
TIME * GROUP 8.23 1 8.23 7.46 0.01 0.18 
Error (TIME) 253.77 230 1.10       
Error (GROUP) 46.2 230 0.20       
Left Insular ROI [-36 11 -5] Brain Activation 
TIME 13.99 1 13.99 64.75 <0.0001 0.47 
GROUP 1.11 1 1.11 4.56 0.034 0.14 
TIME * GROUP 0.21 1 0.21 0.96 0.33* 0.06 
Error (TIME) 49.05 227 0.22       
Error (GROUP) 55.46 227 0.24       
Left Caudate ROI [-12 5 10] Brain Activation 
TIME 0.39 1 0.33 1.71 0.19* 0.09 
GROUP 0.18 1 0.18 3.04 0.08* 0.14 
TIME * GROUP 0.73 1 0.73 3.20 0.07* 0.12 
Error (TIME) 52.78 230 0.23       
Error (GROUP) 13.99 230 0.06       
Right Prefrontal ROI [6 65 31] Brain Activation 
TIME 4.83 1 4.83 6.98 0.01 0.17 
GROUP 1.15 1 1.15 4.21 0.04 0.13 
TIME * GROUP 2.19 1 2.15 3.17 0.08* 0.12 
Error (TIME) 159.10 230 0.69       
Error (GROUP) 62.56 230 0.27       
Right Parahippocampal ROI [33 -46 -5] Brain Activation 
TIME 3.17 1 3.17 12.11 0.001 0.22 
GROUP 0.45 1 0.45 4.90 0.03 0.14 
TIME * GROUP 0.72 1 0.72 2.761 0.1* 0.11 
Error (TIME) 60.25 230 0.26 
Error (GROUP) 21.36 230 0.09       
Abbreviations 
df: degrees of Freedom; F: F-ratio; (*): not statistically significant at a p=0.05 level; r: 
Pearson’s correlation coefficient. 
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Table 3: CANTAB Measures Factorial Analysis 
Factorial Analysis, Mixed Model 2-way ANOVA 
CANTAB Variable Factors Type III Sum 
of Squares df, dfR 
Mean 
Square F value P value r value 
AGN Total Omissions Negative GROUP 73.82 1, 16 73.82 2.5 .12* 0.12 
TIME 3006.21 1, 16 3006.21 50.24 <0.0001 0.49
GROUP * TIME 144.6 1, 16 144.6 2.42 .12* 0.12
AGN Total Omissions Positive GROUP 77.1 1, 16 77.1 2.92 .1* 0.13 
TIME 3423.72 1, 16 3423.72 58.78 <0.0001 0.52 
GROUP * TIME 77.33 1, 16 77.33 1.33 .25* 0.09 
Abbreviations 
AGN Total Omissions Negative/Positive: Affective Go-NoGo Task, total number of missed responses to targets in the blocks specified by 
the value of target type (negative, positive); CANTAB: Cambridge Neuropsychological Test Automated Battery;  
df: degrees of Freedom; dfR: df(Error) F: F-ratio; r: Pearson’s correlation coefficient: (*): not statistically significant at a P=.05 level. 
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Table 4: Overall Results of Mean Brain Activation and CANTAB Measures Factorial and Exploratory Analysis 
Brain ROI / CANTAB measure Factorial Analysis 
(significant effects) 
Exploratory Analysis 
Age 14 Change between 14 and 19 Age 19 
Brain ROIs Left Insular Cortex [-36 11 -5] Group, Time L>H H ↓ L ↓  
Right Insular Cortex [42 8 -14] Group, Group*Time H>L H ↓ NS L ↑  
Left Caudate Body [-12 5 10]     L>H 
Right Superior Frontal Gyrus [6 65 31] Group, Time  H ↑ NS L ↑ L>H 
Right Limbic Cortex [33 -46 -5] Group, Time  H ↓ L ↓ NS L>H 
CANTAB 
measure 
AGN Total Omissions, Positive Stimuli Time L>H H ↓ L ↓  
AGN Total Omissions, Negative Stimuli Time L>H H ↓ L ↓  
H: High PLEs Group; L: Low PLEs Group;  
↑: Increase in brain activation or CANTAB score (statistically significant); 
↑ NS: Increase in brain activation or CANTAB score (statistically non-significant); 
↓: Decrease in brain activation or CANTAB score (statistically significant); 
↓ NS: Decrease in brain activation or CANTAB score (statistically non-significant)
 
 


